Enhanced NF-κB signaling in type-2 dendritic cells at baseline predicts non-response to adalimumab in psoriasis.
Andres-Ejarque R, Ale HB, Grys K, Tosi I, Solanky S, Ainali C, Catak Z, Sreeneebus H, Saklatvala J, Dand N, de Rinaldis E, Chapman A, Nestle FO, Barnes MR, Warren RB, Reynolds NJ, Griffiths CEM, Barker JN, Smith CH, Di Meglio P; PSORT Consortium.
Andres-Ejarque R, et al. Among authors: nestle fo.
Nat Commun. 2021 Aug 6;12(1):4741. doi: 10.1038/s41467-021-25066-9.
Nat Commun. 2021.
PMID: 34362923
Free PMC article.